A network-oriented perspective on cardiac calcium signaling

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 9, 2012, Pages

  George, Christopher H ^a   Parthimos, Dimitris ^a   Silvester, Nicole C ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Calcium; Chaos; Heart oscillation; Network; Plasticity; Synchronization

Indexed keywords

CAFFEINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN KINASE C; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

CALCIUM SIGNALING; CELL SYNCHRONIZATION; CYTOARCHITECTURE; GENE EXPRESSION; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; INTRACELLULAR SIGNALING; MALADJUSTMENT; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SARCOLEMMA; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM SIGNALING; HEART; HEART DISEASES; HUMANS; MICE; MODELS, CARDIOVASCULAR; RATS;

EID: 84868322954     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00388.2011     Document Type: Review

References (180)

1. Abozguia K, Elliott P, McKenna W, Phan TT, Nallur-Shivu G, Ahmed I, Maher AR, Kaur K, Taylor J, Henning A, Ashrafian H, Watkins H, Frenneaux M. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 122: 1562-1569, 2010.
2. Alexeyenko A, Sonnhammer ELL. Global networks of functional coupling in eukaryotes from comprehensive data integration. Genome Res 19: 1107-1116, 2009.
3. Amaral LAN, Scala A, Barthelemy M, Stanley HE. Classes of smallworld networks. Proc Natl Acad Sci USA 97: 11149-11152, 2000.
4. Andersson KB, Birkeland JAK, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien K, Sejerstad OM, Christensen G. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 47: 180-187, 2009.
5. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100: 474-488, 2007.
6. Ashrafian H, McKenna WJ, Watkins H. Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res 109: 86-96, 2011.
7. Atar D, Backx PH, Appel MM, Gao WD, Marban E. Excitationtranscription coupling mediated by zinc influx through voltage-dependent calcium channels. J Biol Chem 270: 2473-2477, 1995.
8. Barry WH, Gilbert EM. How do beta-blockers improve ventricular function in patients with congestive heart failure? Circulation 107: 2395-2397, 2003.
9. Belevych AE, Terentyev D, Terentyeva R, Nishijima Y, Sridhar A, Hamlin RL, Carnes CA, Gyorke S. The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc Res 90: 493-502, 2011.
10. Berry JM, Le V, Rotter D, Battiprolu PK, Grinsfelder B, Tannous P, Burchfield JS, Czubryt M, Backs J, Olson EN, Rothermel BA, Hill JA. Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res 109: 407-417, 2011.
11. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70: 23-49, 2008.
12. Bers DM. Calcium handling, contraction, and ryanodine receptors: integration for cardiac "electricians". Dialogues Cardiovasc Med 15: 247-252, 2010.
13. Bers DM. Macromolecular complex regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37: 417-429, 2004.
14. Bers DM. Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring. Circ Res 110: 796-799, 2012.
15. Bhalla US, Iyengar R. Emergent properties of networks of biological signaling pathways. Science 283: 381-387, 1999.
16. Bhola PD, Simon SM. Determinism and divergence of apoptosis susceptibility in mammalian cells. J Cell Sci 122: 4296-4302, 2009.
17. Bhuiyan ZA, van den Berg MP, van Tintelen P, Bink-Boelkens MT, Wiesfeld AC, Alders M, Postma AV, van Langen I, Mannens MM, Wilde AA. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 116: 1569-1576, 2007.
18. Bien H, Yin l, Entcheva E. Calcium instabilities in mammalian cardiomyocyte networks. Biophys J 90: 2628-2640, 2006.
19. Boogerd FC, Bruggeman FJ, Hofmeyr JHS, Westerhoff HV. Afterthoughts as foundations for systems biology. In: Systems Biology: Philosophical Foundations, edited by Boogerd FC, Bruggeman FJ, Hofmeyr J-HS, and Westerfhoff HV. Amsterdam: Elsevier, 2007, p. 321-336.
20. Breitling R. What is systems biology? Front Physiol 1: 9, 2010.
21. Brown DA, O'Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res 88: 241-249, 2010.
22. Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dinaano VL, Lardo AC, Abraham TP, Tomaselli GF, Kass DA. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117: 1369-1377, 2008.
23. Chapman J. System Failure (Online). London: Demos. 2004. [available at http://wwwdemos.co.uk/files/systemfailure2].
24. Chialvo DR, Gilmour RF Jr, Jalife J. Low dimensional chaos in cardiac tissue. Nature 343: 653-657, 1990.
25. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95: 2979-2984, 1998.
26. Cook SA, Clerk A, Sugden PH. Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? J Mol Cell Cardiol 46: 118-129, 2008.
27. Csete ME, Doyle JC. Reverse engineering of biological complexity. Science 295: 1664-1669, 2002.
28. Dai S, Hall DD, Hell JW. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 80: 411-452, 2009.
29. Dehmelt L, Bastiaens PI. Spatial organization of intracellular communication: insights from imaging. Nat Rev Mol Cell Biol 11: 440-452, 2010.
30. 2+-ATPase in a rat model of heart failure. Circulation 104: 1424-1429, 2001.
31. Dhein S. Pharmacology of gap junctions in the cardiovascular system. Cardiovasc Res 62: 287-298, 2004.
32. Dodge-Kafka KL, Kapiloff MS. The mAKAP signalling complex: integration of cAMP, calcium and MAP kinase signalling pathways. Eur J Cell Biol 85: 593-602, 2006.
33. Dolmetsch R. Excitation-transcription coupling: signaling by ion channels to the nucleus. Sci STKE 166: pe4, 2003.
34. Dorn IIGW, Scorrano L. Two close, too close: sarcoplasmic reticulummitochondrial crosstalk and cardiomyocyte fate. Circ Res 107: 689-699, 2010.
35. Eisner DA, Choi HS, Diaz ME, O'Neill SC, Trafford AW. Integrative analysis of calcium cycling in cardiac muscle. Circ Res 87: 1087-1094, 2000.
36. Eldar A, Elowitz MB. Functional roles for noise in genetic circuits. Nature 467: 167-173, 2010.
37. Fernandez-Suarez M, Ting AY. Fluorescent probes for super-resolution imaging in living cells. Nat Rev Mol Cell Biol 9: 929-943, 2008.
38. R4996C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res 104: 201-209, 2009.
39. Figeys D. Mapping the human protein interactome. Cell Res 18: 716-724, 2008.
40. Fischer RS, Wu Y, Kanchanawong P, Shroff H, Waterman CM. Microscopy in 3D: a biologist's toolbox. Trends Cell Biol 21: 682-691, 2011.
41. Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285: 14071-14077, 2010.
42. Gandhi TKB, Zhong J, Mathivanan S, Karthick L, Chandrika KN, Mohan SS, Sharma S, Pinkert S, Nagaraju S, Periaswamy B, Mishra G, Nandakumar K, Shen B, Deshpande N, Nayak R, Sarker M, Boeke JD, Parmigiani G, Schultz J, Bader JS, Pandey A. Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet 38: 285-293, 2006.
43. Garfinkel A, Spano ML, Ditto WL, Weiss JN. Controlling cardiac chaos. Science 257: 1230-1235, 1992.
44. 2+ leak in heart failure: mere observation or functional relevance? Cardiovasc Res 77: 302-314, 2008.
45. George CH, Barberini-Jammaers SR, Muller CT. Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux. Expert Opin Ther Pat 18: 1-19, 2008.
46. George CH, Higgs GV, Lai FA. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 93: 531-540, 2003.
47. George CH, Jundi H, Thomas NL, Fry DL, Lai FA. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies. J Mol Cell Cardiol 42: 34-50, 2007.
48. 2+ release channel dysfunction. Circ Res 98: 88-97, 2006.
49. 2+ release channel dysfunction. Curr Pharm Des 13: 3195-3211, 2007.
50. 2+ signaling and susceptibility to apoptosis. Circ Res 100: 874-883, 2007.
51. Glass L. Synchronization and rhythmic processes in physiology. Nature 410: 277-284, 2001.
52. Glass L, Mackey MC. Pathological conditions resulting from instabilities in physiological control systems. Ann NY Acad Sci 316: 214-235, 1979.
53. Glass L, Zeng WZ. Complex bifurcations and chaos in simple theoretical models of cardiac oscillations. Ann NY Acad Sci 591: 316-327, 2006.
54. Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 347: 1312-1314, 1996.
55. Greenstein JL, Winslow RL. Integrative systems models of cardiac excitation-contraction coupling. Circ Res 108: 70-84, 2011.
56. Griffith TM, Parthimos D, Edwards DH. Non-linear analysis and modelling of the cellular mechanisms that regulate arterial vasomotion. Proc Inst Mech Eng, part C: J Mech Eng Sci 220: 367-381, 2006.
57. Griffith TM, Parthimos D, Edwards DH. Vasomotion: the case for chaos. Biorheology 23: 11-23, 2009.
58. Hartwell LH, Hopfield JJ, Leibler S, Murray AT. From molecular to modular cell biology. Nature 402: C47-C52, 1999.
59. 2+ lightning conveys cell-cell contact information inside the cells. EMBO Rep 7: 1117-1123, 2006.
60. 2+ signaling in the heart. J Cell Sci 122: 1005-1013, 2009.
61. 2+ exchange: cardiac specific knockout of NCX1. Circ Res 95: 604-611, 2004.
62. Heo M, Maslov S, Shakhnovich E. Topology of protein interaction network shapes protein abundances and strengths of their functional and non-specific interactions. Proc Natl Acad Sci USA 108: 4258-4263, 2011.
63. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643, 2004.
64. Houser SR. Does protein kinase A-mediated phosphorylation of the cardiac ryanodine receptor play any role in adrenergic regulation of calcium handling in health and disease. Circ Res 106: 1672-1674, 2010.
65. Houser SR, Piacentino V, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol 32: 1595-1607, 2000.
66. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res 81: 412-419, 2009.
67. Jordan JD, Landau EM, Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 103: 193-200, 2000.
68. Jorgensen C, Sherman A, Chen GI, Pasculescu A, Poliakov A, Hsiung M, Larsen B, Wilkinson DG, Linding R, Pawson T. Cellspecific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 326: 1502-1509, 2009.
69. Kitano H. Grand challenges in systems physiology. Front Physiol 1: 3, 2010.
70. Kubon C, Mistry NB, Grundvold I, Halvorsen S, Kjeldsen SE, Westheim AS. The role of beta-blockers in the treatment of chronic heart failure. Trends Pharmacol Sci 32: 206-212, 2011.
71. Kurz FT, Aon MA, O'Rourke B, Armoundas AA. Spatio-temporal oscillations of individual mitochondria in cardiac myocytes reveal modulation of synchronized mitochondrial clusters. Proc Natl Acad Sci USA 107: 14315-14320, 2010.
72. Ladbury JE, Arold ST. Noise in cellular signaling pathways: causes and effects. Trends Biochem Sci 37: 173-178, 2012.
73. Lage K, Mollgard K, Greenway S, Wakimoto H, Gorham JM, Workman CT, Bendsen E, Hansen NT, Rigina O, Roque FS, Wiese C, Christoffels VM, Roberts AE, Smoot LB, Pu WT, Donahoe PK, Tommerup N, Brunak S, Seidman CE, Seidman JG, Larsen LA. Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol Syst Biol 6: 381, 2010.
74. Lahat H, Pras E, Olender T, Avadan N, Ben-Asher E, Man O, Levy-Nissenbaum E, Khoury A, Lorber A, Goldman B, Lancet D, Eldar M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 69: 1378-1384, 2001.
75. 2+ cycling is a general regulator of how fast and how strong the heart beats. Dialogues Cardiovasc Med 15: 253-278, 2010.
76. Lakatta EG, DiFrancesco D. What keeps us ticking: a funny current, a calcium clock, or both? J Mol Cell Cardiol 47: 157-170, 2009.
77. 2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 106: 659-673, 2010.
78. Lakatta EG, Maltsev VA, Bogdanov KY, Stern MD, Vinogradova TM. Cyclic variation of intracellular calcium: a critical factor for cardiac pacemaker cell dominance. Circ Res 92: E45-E50, 2003.
79. Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, Harvey RD, Richter W, Jin SL, Conti M, Marks AR. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123: 25-35, 2005.
80. Li L, Louch WE, Niederer SA, Aronsen JM, Christensen G, Sejerstad OM, Smith NP. Sodium accumulation in SERCA knockout-induced heart failure. Biophys J 102: 2039-2048, 2012.
81. Lim WA. Designing customized cell signalling circuits. Nat Rev Mol Cell Biol 11: 393-403, 2010.
82. Lippincott-Schwartz J, Patterson GH. Photoactivatable fluorescent proteins for diffraction-limited and super-resolution imaging. Trends Cell Biol 19: 555-565, 2009.
83. Lipsitz LA, Goldberger AL. Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. JAMA 267: 1806-1809, 1992.
84. Liu XH, Zhang ZY, Andersson KB, Husberg C, Enger UH, Raeder MG, Christensen G, Louch WE. Cardiomyocyte-specific disruption of Serca2 in adult mice causes sarco(endo) plasmic reticulum stress and apoptosis. Cell Calcium 49: 201-207, 2011.
85. Lobo PA, Kimlicka L, Tung CC, Van Petegem F. The deletion of exon 3 in the cardiac ryanodine receptor is rescued by strand switching. Structure 19: 790-798, 2011.
86. Lyon AR, Bannister ML, Collins T, Pearce E, Sepehripour AH, Dubb SS, Garcia E, O'Gara P, Liang L, Kohlbrenner E, Hajjar R, Peters NS, Poole-Wilson PA, MacLeod KT, Harding SE. SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure. Circ Arrhythm Electrophysiol 4: 362-372, 2011.
87. Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10: 307-318, 2010.
88. Ma'ayan A, Blitzer RD, Iyengar R. Toward predictive models of mammalian cells. Annu Rev Biophys Biomol Struct 34: 319-349, 2005.
89. Ma'ayan A, Jenkins SL, Neves S, Hasseldine A, Grace E, Dubin-Thaler B, Eungdamrong NJ, Weng G, Ram PT, Rice JJ, Kershenbaum A, Stolovitzky GA, Blitzer RD, Iyengar R. Formation of regulatory patterns during signal propagation in a mammalian cellular network. Science 309: 1078-1083, 2005.
90. Mackey MC, Glass L. Oscillation and chaos in physiological control systems. Science 197: 287-289, 1977.
91. Mair W, Morantte I, Rodrigues AP, Manning G, Montminy M, Shaw RJ, Dillin A. Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 470: 404-408, 2011.
92. Malik FI, Hartman JJ, Elias KA, Morgan BP, Rodriguez H, Brejc K, Anderson RL, Sueoka SH, Lee KH, Finer JT, Sakowicz R, Baliga R, Cox DR, Garard M, Godinez G, Kawas R, Kraynack E, Lenzi D, Lu Pp Muci A, Niu C, Qian X, Pierce DW, Pokrovskii M, Suehiro I, Sylvester S, Tochimoto T, Valdez C, Wang W, Katori T, Kass DA, Shen YT, Vatner SF, Morgans DJ. Cardiac myosin activation: a potential therapeutic approach for systolic heart failure. Science 331: 1439-1443, 2011.
93. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D. Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96: 592-599, 2005.
94. Marx SO, Reiken S, Hisamatsu Y, Gaburjakova M, Gaburjakova J, Yang YM, Rosemblit N, Marks AR. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine-isoleucine zippers. J Cell Biol 154: 699-708, 2001.
95. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
96. Maslov S, Ispolatov I. Propagation of large concentration changes in reversible protein-binding networks. Proc Natl Acad Sci USA 104: 13655-13660, 2007.
97. Maslov S, Sneppen K, Ispolatov I. Spreading out of perturbations in reversible reaction networks. New J Phys 9: 273, 2007.
98. Mattheyses AL, Simon SM, Rappoport JZ. Imaging with total internal reflection fluorescence microscopy for the cell biologist. J Cell Sci 123: 3621-3628, 2010.
99. Mehta S, Zhang J. Reporting from the field: genetically encoded fluorescent reporters uncover signaling dynamics in living biological systems. Annu Rev Biochem 80: 375-401, 2011.
100. Michael G, Xiao L, Qi XY, Dobrev D, Nattel S. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. Cardiovasc Res 81: 491-499, 2009.
101. Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. Network motifs: simple building blocks of complex networks. Science 298: 824-827, 2002.
102. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421: 634-639, 2003.
103. Moreno JD, Zhu ZI, Yang PC, Bankston JR, Jeng MT, Kang C, Wang L, Bayer JD, Christini DJ, Trayanova NA, Ripplinger CM, Kass RS, Clancy CE. Computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms. Sci Transl Med 3: 98ra83, 2011.
104. 2+ release activity in mammalian cells. Mol Syst Biol 5: 1-10, 2009.
105. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 5: 1034-1049, 2006.
106. Neubauer S. Mechanisms of disease: the failing heart-an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
107. Noujaim SF, Berenfeld O, Kalifa J, Cerrone M, Nanthakumar K, Atienza F, Moreno J, Mironov S, Jalife J. Universal scaling law of electrical turbulence in the mammalian heart. Proc Natl Acad Sci USA 104: 20985-20989, 2007.
108. Novak B, Tyson JJ. Design principles of biochemical oscillators. Nat Rev Mol Cell Biol 9: 981-991, 2008.
109. Novak P, Li C, Shevchuk AI, Stepanyan R, Caldwell M, Hughes S, Smart TG, Gorelik J, Ostanin VP, Lab MJ, Moss GWJ, Frolenkov GI, Klenerman D, Korchev YE. Nanoscale live-cell imaging using hopping probe ion conductance microscopy. Nat Methods 6: 279-281, 2009.
110. Park JM, Kim TY, Lee SY. Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proc Natl Acad Sci USA 107: 14931-14936, 2010.
111. 2+ oscillators. Am J Physiol Heart Circ Physiol 277: H1119-H1144, 1999.
112. Pinz I, Tian R, Swanson E, Dillmann W, Ingwall JS. Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a. J Biol Chem 286: 10163-10168, 2011.
113. Pool R. Is it healthy to be chaotic? Science 243: 604-607, 1989.
114. 2+ flux. Circ Res 97: 1288-1295, 2005.
115. 2+ handling and arrhythmogenesis. Circ Res 108: 871-883, 2011.
116. Quaranta V, Garbett S. Not all noise is waste. Nat Methods 7: 269-272, 2010.
117. Raj A, van den Bogaard P, Rifkin SA, van Oudenaarden A, Tyagi S. Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods 5: 877-879, 2008.
118. Rao CV, Wolf DM, Arkin AP. Control, exploitation and tolerance of intracellular noise. Nature 420: 231-237, 2002.
119. Raser JM, O'Shea EK. Noise in gene expression: origins, consequences, and control. Science 309: 2010-2013, 2005.
120. Raychaudhuri S, Willgohs E, Nguyen TN, Kahn EM, Goldkorn T. Monte Carlo simulation of cell death signaling predicts large cell-to-cell stochastic fluctuations through the type 2 pathway of apoptosis. Biophys J 95: 3559-3562, 2008.
121. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ, Marks AR. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts: role of phosphatases and response to isoproterenol. J Biol Chem 278: 444-453, 2003.
122. 2+ responses. Science 280: 1763-1766, 1998.
123. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 415: 206-212, 2002.
124. Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res 88: 40-50, 2010.
125. Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for moods disorders and schizophrenia. Nat Rev Drug Discov 3: 353-359, 2004.
126. Ruiz-Meana M, Fernandez-Sanz C, Garcia-Dorado D. The SR-mitochondria interaction: a new player in cardiac pathophysiology. Cardiovasc Res 88: 30-39, 2010.
127. Sarkar AX, Christini DJ, Sobie EA. Exploiting mathematical models to illuminate electrophysiological variability between individuals. J Physiol 590: 2555-2567, 2012.
128. Sartori P, Tu Y. Noise filtering strategies in adaptive biochemical signaling networks. J Stat Phys 142: 1206-1217, 2011.
129. Sato D, Xie LH, Nguyen TN, Weiss JN, Qu Z. Irregularly appearing early after-depolarizations in cardiac myocytes: random flucuatations or dynamical chaos? Biophys J 99: 765-773, 2010.
130. Satoh M, Matter CM, Ogita H, Takeshita K, Wang CY, Dorn GW 2nd, Liao JK. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115: 3197-3204, 2007.
131. Schermellah L, Heintzmann R, Leonhardt H. A guide to superresolution fluorescence microscopy. J Cell Biol 190: 165-175, 2010.
132. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299: 1410-1413, 2003.
133. Sharma V. Deterministic chaos and fractal complexity in the dynamics of cardiovascular behavior: perspectives on a new frontier. Open Cardiovasc Med J 3: 110-123, 2009.
134. 2+ fluxes in cardiomyocyte syncitia predicts the response to pro-arrhythmic stimuli. Biophys J 98: 105a, 2010.
135. 2+-cycling basis of rhythmicity and synchronicity in coupled cardiomyocyte monolayers. Biophys J Suppl 96: 273a-274a, 2009.
136. Silvester NC, George CH. Searching for new cardiovascular drugs: towards improved systems for drug screening? Expert Opin Drug Discov 6: 1155-1170, 2011.
137. Snijder B, Pelkmans L. Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol 12: 119-125, 2011.
138. Song DW, Lee JG, Youn HS, Eom SH, Kim DH. Ryanodine receptor assembly: a novel systems biology approach to 3D mapping. Prog Biophys Mol Biol 105: 145-161, 2011.
139. Song Y, Altarejos J, Goodarzi MO, Inoue H, Guo X, Berdeaux R, Kim JH, Goode J, Igata M, Paz JC, Hogan MF, Singh PK, Goebel N, Vera L, Miller N, Ciu J, Jones MR, CHARGE consortium, GIANT consortium, Chen YD, Taylor KD, Hseuh WA, Rotter JI, Montminy M. CRTC3 links catecholamine signalling to energy balance. Nature 468: 933-939, 2010.
140. Sosnovick DE, Nahrendorf M, Panizzi P, Matsui T, Aikawa E, Dai G, Li L, Reynolds F, Dorn IIGW, Weissleder R, Josephson L, Roesenzweig A. Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure. Circ Cardiovasc Imaging 2: 468-475, 2009.
141. Sperling SR. Systems biology approaches to heart development and congenital heart disease. Cardiovasc Res 91: 269-278, 2011.
142. Spiller DG, Wood CD, Rand DA, White MR. Measurement of singlecell dynamics. Nature 465: 736-745, 2010.
143. v1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19-31, 2004.
144. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129, 2005.
145. Strogatz SH. Exploring complex networks. Nature 410: 268-276, 2001.
146. Swift F, Franzini-Armstrong C, Oyehaug L, Enger UH, Andersson KB, Christensen G, Sejerstad OM, Louch WE. Extreme sarcoplasmic reticulum volume loss and compensatory T-tubule remodeling after Serca2 knockout. Proc Natl Acad Sci USA 109: 3997-4001, 2012.
147. Szalai G, Csordas G, Hantash BM, Thomas AP, Hajnoczky G. Calcium signal transmission between ryanodine receptors and mitochondria. J Biol Chem 275: 15305-15513, 2000.
148. Takens F. Detecting strange attractors in turbulence. In: Dynamical Systems and Turbulence: Lecture Notes in Mathematics, vol. 898. New York: Springer-Verlag, 1981, pp. 366-381.
149. Thomas NL, George CH, Williams AJ, Lai FA. Ryanodine receptor mutations in arrhythmias: advances in understanding the mechanisms of channel dysfunction. Biochem Soc Trans 35: 946-951, 2007.
150. 2+ fluxes in rat ventricular myocytes. J Physiol 522: 259-270, 2000.
151. Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure. Cardiovasc Res 90: 251-257, 2011.
152. Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15: 221-231, 2003.
153. Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto M, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circ Res 106: 1413-1424, 2010.
154. Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves-threshold sarcoplasmic reticulum calcium content is required. Circ Res 100: 105-111, 2007.
155. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 555: 1-13, 2004.
156. Vest JA, Wehrens XHT, Reiken SR, Lehnart SE, Dobrev DD, Chandra P, Danilo P, Ravens U, Rosen M, Marks AR. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111: 2025-2032, 2005.
157. Vinayagam A, Stezl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE, Andrada-Navarro MA, Wanker EE. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 4: rs8, 2011.
158. 2+ release during diastolic depolarization of sinoatrial pacemaker cells do not require membrane depolarization. Circ Res 94: 802-809, 2004.
159. 2+/calmodulin kinase signaling pathway. Circ Res 95: 798-806, 2004.
160. Wang X, Wei X, Thijssen B, Das J, Lipkin SM, Yu H. Threedimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30: 159-164, 2012.
161. Wasserstrom JA, Sharma R, Kapur S, Kelly JE, Kadish AH, Balke CW, Aistrup GL. Multiple defects in intracellular calcium cycling defects in whole failing rat heart. Circ Heart Fail 2: 223-232, 2009.
162. Watts DJ, Strogatz SH. Collective dynamics of 'small-world' networks. Nature 393: 440-442, 1998.
163. Wehrens XHT, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113: 829-840, 2003.
164. Wehrens XHT, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci USA 103: 511-518, 2006.
165. Wehrens XHT, Lehnart SE, Reiken SR, Deng SX, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin Science 304: 292-296, 2004.
166. Weiss JN. How does falling out of phase of intracellular calcium and action potentials across the heart's wall spell the beginning of chaos for the heart? Dialogues Cardiovasc Med 15: 302-310, 2010.
167. Welch CM, Elliot H, Danuser G, Hahn KM. Imaging the coordination of multiple signalling activities in living cells. Nat Rev Mol Cell Biol 12: 749-756, 2011.
168. Wiesenfeld K, Moss F. Stochastic resonance and the benefits of noise: from ice ages to crayfish and SQUIDs. Nature 373: 33-36, 1995.
169. 2+] in vascular smooth muscle cells. Am J Physiol Cell Physiol 280: C843-C851, 2001.
170. 2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 116: 675-682, 2006.
171. Xiang YK. Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res 109: 231-244, 2011.
172. Yang HT, Tweedie D, Wang S, Guia A, Vinogradova T, Bogdanov K, Allen PD, Stern MD, Lakatta EG, Boheler KR. The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci USA 99: 9225-9230, 2002.
173. Yano M, Yamamoto T, Ikemoto N, Matsuzaki M. Abnormal ryanodine receptor function in heart failure. Pharmacol Ther 107: 377-391, 2005.
174. Yosef N, Zalckvar E, Rubinstein AD, Homilius M, Atias N, Vardi L, Berman I, Zur H, Kimchi A, Ruppin E, Sharan R. ANAT: a tool for constructing and analyzing functional protein networks. Sci Signal 4: pl1, 2011.
175. Zhang J, Maslov S, Shakhnovich EI. Constraints imposed by nonfunctional protein-protein interactions on gene expression and proteome size. Mol Syst Biol 4: 210, 2008.
176. 2+ handling but exacerbates cardiac dysfunction in CaMKIIc transgenic mice. Circ Res 106: 354-362, 2010.
177. 2+ indicators. Science 333: 1888-1891, 2011.
178. Zheng M, Zhu W, Han Q, Xiao RP. Emerging concepts and therapeutic implications of β-adrenergic receptor subtype signaling. Pharmacol Ther 108: 257-268, 2005.
179. i signaling in the heart: the good, the bad, and the ugly. Circ Res 97: 507-509, 2005.
180. Ziviani E, Lippi G, Bano D, Munarriz E, Guiducci S, Zoli M, Young KW, Nicotera P. Ryanodine receptor-2 upregulation and nicotine-mediated plasticity. EMBO J 30: 194-204, 2011.